FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 26.9

Change

+0.14 (+0.52)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+0.05 (+0.04%)

USD 14.94B
IWP iShares Russell Mid-Cap Growth..

+0.05 (+0.04%)

USD 14.94B
VOT Vanguard Mid-Cap Growth Index ..

+0.60 (+0.25%)

USD 14.12B
VOT Vanguard Mid-Cap Growth Index ..

+0.60 (+0.25%)

USD 14.12B
IJK iShares S&P Mid-Cap 400 Growth..

+0.08 (+0.09%)

USD 9.84B
IJK iShares S&P Mid-Cap 400 Growth..

+0.08 (+0.09%)

USD 9.84B
XMMO Invesco S&P MidCap Momentum ET..

+0.44 (+0.37%)

USD 2.43B
XMMO Invesco S&P MidCap Momentum ET..

+0.44 (+0.37%)

USD 2.43B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.05 (+0.04%)

USD 1.08B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.05 (+0.04%)

USD 1.08B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.38% 21% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.38% 15% F 48% F
Trailing 12 Months  
Capital Gain 20.95% 17% F 58% F
Dividend Return 0.71% 44% F 8% B-
Total Return 21.66% 17% F 51% F
Trailing 5 Years  
Capital Gain -14.58% 6% D- 25% F
Dividend Return 2.72% 34% F 8% B-
Total Return -11.85% 6% D- 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.86% N/A N/A 27% F
Dividend Return -1.20% N/A N/A 18% F
Total Return 0.66% N/A N/A 16% F
Risk Return Profile  
Volatility (Standard Deviation) 29.56% N/A N/A 35% F
Risk Adjusted Return -4.05% N/A N/A 22% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike